We have a good chance
$Elevai Labs (ELAB.US)$ so current the rsi is at 27 meaning that this stock i oversold so in short term this could often indicate a potential for rebound, the next resistance is .04 to .05 range, well a significant upward move would be .10, future developments for elab new clinical trial results, partnerships, or product rollouts could be catalysts for a more favorable valuation,i n the current market and without a significant change in financials or clinical results, a short-term target of $0.05 (about a 90% increase from current levels) would be an aggressive but feasible target if buying interest returns. A more conservative 6-month target for ELAB could remain between $0.04 - $0.05 if no strong financial or technological catalysts emerge to draw sustained investor interest. However, should new developments arise, a target of $0.10 could become realistic but would rely on positive, market-moving news or partnerships.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Mutawakkil : will RS be implemented or not necessary?
王君403 : I have been ready for a year to take it.
王君403 : There is no such thing as a loss, I will hold on until this time next year.